details

Peer companies

;

Share Market News

Veerhealth Care is currently trading at Rs. 18.99, up by 0.53 points or 2.87% from its previous closing of Rs. 18.46 on the BSE.The scrip opened at Rs. 18.85 and has touched a high and low of Rs. 19.27 and Rs. 18.36 respectively. So far 1,20,000 shares were traded on the counter.The BSE group `X` stock of face value Rs. 10 has touched a 52 week high of Rs. 19.42 on 27-Dec-2017 and a 52 week low of Rs. 9.00 on 16-Nov-2017.Last one week high and low of the scrip stood at Rs. 19.42 and Rs. 15.50 respectively. The current market cap of the company is Rs. 128.28 crore.The promoters holding in the company stood at 38.67%, while Non-Institutions held 61.33% respectively.Veerhealth Care has purchased industrial plot at Vapi in state of Gujarat for expansion of its existing capacity.The company has decided to construct and set up factory on the industrial plot and install new machines for increasing production capacity. The estimated cost for setting up new unit at Vapi will be around Rs 10 crore. Veerhealth Care has started in trading activities in pharma products. The company intends to manufacture pharmaceuticals at Ahmedabad.

Veerhealth Care is currently trading at Rs. 19.21, up by 1.55 points or 8.78% from its previous closing of Rs. 17.66 on the BSE. The scrip opened at Rs. 18.90 and has touched a high and low of Rs. 19.42 and Rs. 18.50 respectively. So far 203428 shares were traded on the counter.The BSE group `X` stock of face value Rs. 10 has touched a 52 week high of Rs. 19.42 on 27-Dec-2017 and a 52 week low of Rs. 9.00 on 16-Nov-2017.Last one week high and low of the scrip stood at Rs. 19.42 and Rs. 15.50 respectively. The current market cap of the company is Rs. 13.18 crore.The promoters holding in the company stood at 38.67%, while Non-Institutions held 61.33% stake in the company. Veerhealth Care has purchased industrial plot at Vapi in state of Gujarat for expansion of its existing capacity.The company has decided to construct and set up factory on the industrial plot and install new machines for increasing production capacity. The estimated cost for setting up new unit at Vapi will be around Rs 10 crore. Veerhealth Care has started in trading activities in pharma products. The company intends to manufacture pharmaceuticals at Ahmedabad.

Veerhealth Care has informed that a meeting of the Board of Directors of the Company will be held on May 27, 2016, to consider and approve Financial Results for the year ended March 31, 2016 and the Audited Balance Sheet as at March 31, 2016, Profit & Loss Account for the year ended on that date; and to appoint Ravindra V. Joshi, Practicing Company Secretary as Secretarial Auditor of the Company for the financial year 2015-2016 and fix remuneration. Further, pursuant to the Code of Conduct for Prevention of Insider Trading in the shares of the Company, the Trading Window for dealing in the shares of the Company will remain closed for all the designated employees and directors from May 19, 2016 to May 29, 2016.The above information is a part of company’s filings submitted to BSE.

Veerhealth Care has informed about authorised KMPs to determine materiality of events/information.The above information is a part of company’s filings submitted to BSE.

Veerhealth Care has informed that Metropolitan Stock Exchange of India has given listing approval for the Company’s 69,342,384 equity shares and have been admitted for dealing and trading with effect from January 08, 2016.The above information is a part of company’s filings submitted to BSE.

Veerhealth Care is currently trading at Rs 2.60, up by 0.40 points or 18.18% from its previous closing of Rs 2.20 on the BSE.The scrip opened at Rs 2.60 and has touched a high and low of Rs. 2.60 and Rs. 2.17 respectively. So far 20 shares were traded on the counter.The BSE group 'B' stock of face value Rs. 1 has touched a 52 week high of Rs. 4.50 on 07-Nov-2014 and a 52 week low of Rs. 1.80 on 11-Jun-2015.Last one week high and low of the scrip stood at Rs. 2.80 and Rs. 2.13 respectively. The current market cap of the company is Rs. 18.03 crore.The promoters holding in the company stood at 38.30% while Non-Institutions held 61.70%.Veerhealth Care has signed a Memorandum of Understanding (MOU) with Rajnish Hot Deals for developing and manufacturing Ayurvedic Range of hair products at its Changodar Factory, Ahmedabad. The product range would be in the form of Oil, Tablet and Capsule under the brand name of Madamrit Oil, Madamrit Tablet and Madamrit Capsule respectively.Madamrit hair oil is developed through Kshir Pak Vidhi Using 27 conventional herbs like, Brahmi, Aritha, Chanothi, etc. This is an effective remedy for hair fall, dandruff, weak roots, split ends, hair breakage, dryness, white hair, etc. This new introduction would help company to increase its turnover and profits in the current financial year.Veerhealth Care (formerly known as Niyati Industries) was originally engaged mainly in business of trading and investing in shares and securities. The management of the company has decided to diversify the business activities and changed its main object from Leasing and Finance to Pharma sector and new name of the company is VeerHealth Care.

Veerhealth Care has informed that the Annual General Meeting (AGM) of the Company was held on September 12, 2014.The above information is a part of company’s filings submitted to BSE

Veerhealth Care has informed about the Standalone Financial Results & a copy of the Limited Review Report for the period ended June 30, 2014.The above information is a part of company’s filings submitted to BSE

Veerhealth Carehas informed that the Board of Directors of the Company at its meeting held on August 04, 2014, inter alia, have decided to call the 22nd Annual General Meeting on September 12, 2014 at 12.00 p.m. at 6, New Nandu Industrial estate, Mahakali Caves Road, Andheri (E), Mumbai - 400093.The above information is a part of company’s filings submitted to BSE

Veerhealth Care has submitted a Copy of the Limited Review Report for the period ended March 31, 2014.The above information is a part of company’s filings submitted to BSE.

Veerhealth Care has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992.The above information is a part of company’s filings submitted to BSE.

Veerhealth Care has submitted the disclosure under Regulation 13(4A) of the SEBI (Prohibition of Insider Trading) Regulations, 1992.The above information is a part of company’s filings submitted to BSE.